101. ALK positively regulates MYCN activity through repression of HBP1 expression.
- Author
-
Claeys S, Denecker G, Durinck K, Decaesteker B, Mus LM, Loontiens S, Vanhauwaert S, Althoff K, Wigerup C, Bexell D, Dolman E, Henrich KO, Wehrmann L, Westerhout EM, Demoulin JB, Kumps C, Van Maerken T, Laureys G, Van Neste C, De Wilde B, De Wever O, Westermann F, Versteeg R, Molenaar JJ, Påhlman S, Schulte JH, De Preter K, and Speleman F
- Subjects
- Animals, Cell Line, Tumor, Cell Proliferation genetics, Down-Regulation genetics, Forkhead Box Protein O3 genetics, Gene Expression Regulation, Neoplastic genetics, Humans, Mice, MicroRNAs genetics, Mutation genetics, Phosphatidylinositol 3-Kinases genetics, Proto-Oncogene Proteins c-akt genetics, Signal Transduction genetics, Transcriptional Activation genetics, Anaplastic Lymphoma Kinase genetics, High Mobility Group Proteins genetics, N-Myc Proto-Oncogene Protein genetics, Neuroblastoma genetics, Repressor Proteins genetics
- Abstract
ALK mutations occur in 10% of primary neuroblastomas and represent a major target for precision treatment. In combination with MYCN amplification, ALK mutations infer an ultra-high-risk phenotype resulting in very poor patient prognosis. To open up opportunities for future precision drugging, a deeper understanding of the molecular consequences of constitutive ALK signaling and its relationship to MYCN activity in this aggressive pediatric tumor entity will be essential. We show that mutant ALK downregulates the 'HMG-box transcription factor 1' (HBP1) through the PI
3 K-AKT-FOXO3a signaling axis. HBP1 inhibits both the transcriptional activating and repressing activity of MYCN, the latter being mediated through PRC2 activity. HBP1 itself is under negative control of MYCN through miR-17~92. Combined targeting of HBP1 by PI3 K antagonists and MYCN signaling by BET- or HDAC-inhibitors blocks MYCN activity and significantly reduces tumor growth, suggesting a novel targeted therapy option for high-risk neuroblastoma.- Published
- 2019
- Full Text
- View/download PDF